NAT10 Regulates P53 Activation Through Acetylating P53 at K120 and Ubiquitinating Mdm2

Overview

Journal EMBO Rep

Specialty Molecular Biology

Date 2016 Feb 17

PMID 26882543

Citations 92

Authors

Xiaofeng Liu

Yuqin Tan

Chunfeng Zhang

Ying Zhang

Liangliang Zhang

Pengwei Ren

Hongkui Deng

Jianyuan Luo

Yang Ke

Xiaojuan Du

Affiliations

Soon will be listed here.

Abstract

As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor.

Citing Articles

Biological function and mechanism of NAT10 in cancer.

Han Y, Zhang X, Miao L, Lin H, Zhuo Z, He J Cancer Innov. 2025; 4(1):e154.

PMID: 39817252 PMC: 11732740. DOI: 10.1002/cai2.154.

The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.

RNA N4-acetylcytidine modification and its role in health and diseases.

Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G MedComm (2020). 2025; 6(1):e70015.

PMID: 39764566 PMC: 11702397. DOI: 10.1002/mco2.70015.

Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase.

Xiao B, Wu S, Tian Y, Huang W, Chen G, Luo D Cell Biol Toxicol. 2024; 41(1):17.

PMID: 39725720 PMC: 11671434. DOI: 10.1007/s10565-024-09962-6.

RNA modifications: emerging players in the regulation of reproduction and development.

Wen J, Zhu Q, Liu Y, Gou L Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):33-58.

PMID: 39574165 PMC: 11802351. DOI: 10.3724/abbs.2024201.

References

Linares L, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O . Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol. 2007; 9(3):331-8. DOI: 10.1038/ncb1545. View

Yuan J, Luo K, Zhang L, Cheville J, Lou Z . USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010; 140(3):384-96. PMC: 2820153. DOI: 10.1016/j.cell.2009.12.032. View

Kong R, Zhang L, Hu L, Peng Q, Han W, Du X . hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem. 2010; 286(9):7139-48. PMC: 3044971. DOI: 10.1074/jbc.M110.173393. View

Meng L, Lin T, Tsai R . Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci. 2008; 121(Pt 24):4037-46. PMC: 5048913. DOI: 10.1242/jcs.037952. View

Xu C, Fan C, Wang X . Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene. 2014; 34(3):281-9. DOI: 10.1038/onc.2013.557. View

Zhang Y, Xiong Y, Yarbrough W . ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998; 92(6):725-34. DOI: 10.1016/s0092-8674(00)81401-4. View

Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View

Lee S, Kim J, Kim Y, Seok K, Kim J, Chang Y . Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses. Cell Death Differ. 2012; 19(10):1613-22. PMC: 3438492. DOI: 10.1038/cdd.2012.40. View

Luo J, Li M, Tang Y, Laszkowska M, Roeder R, Gu W . Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci U S A. 2004; 101(8):2259-64. PMC: 356938. DOI: 10.1073/pnas.0308762101. View

10.

Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P . NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016; 17(3):349-66. PMC: 4772976. DOI: 10.15252/embr.201540505. View

11.

Kubbutat M, Jones S, Vousden K . Regulation of p53 stability by Mdm2. Nature. 1997; 387(6630):299-303. DOI: 10.1038/387299a0. View

12.

Berndsen C, Wolberger C . New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 2014; 21(4):301-7. DOI: 10.1038/nsmb.2780. View

13.

Lv J, Liu H, Wang Q, Tang Z, Hou L, Zhang B . Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun. 2003; 311(2):506-13. DOI: 10.1016/j.bbrc.2003.09.235. View

14.

Fang S, Jensen J, Ludwig R, Vousden K, Weissman A . Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem. 2000; 275(12):8945-51. DOI: 10.1074/jbc.275.12.8945. View

15.

Lorick K, Jensen J, Fang S, Ong A, Hatakeyama S, Weissman A . RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A. 1999; 96(20):11364-9. PMC: 18039. DOI: 10.1073/pnas.96.20.11364. View

16.

Thut C, Goodrich J, Tjian R . Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev. 1997; 11(15):1974-86. PMC: 316412. DOI: 10.1101/gad.11.15.1974. View

17.

Honda R, Yasuda H . Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 1999; 18(1):22-7. PMC: 1171098. DOI: 10.1093/emboj/18.1.22. View

18.

Tang Y, Luo J, Zhang W, Gu W . Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell. 2006; 24(6):827-39. DOI: 10.1016/j.molcel.2006.11.021. View

19.

Krummel K, Lee C, Toledo F, Wahl G . The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci U S A. 2005; 102(29):10188-93. PMC: 1177381. DOI: 10.1073/pnas.0503068102. View

20.

Kubbutat M, Ludwig R, Levine A, Vousden K . Analysis of the degradation function of Mdm2. Cell Growth Differ. 1999; 10(2):87-92. View